Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Developing a clinical-pathologic model to predict genomic risk of recurrence in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative, node negative breast cancer.
Batra A, Nixon NA, Roldan-Urgoiti G, Hannouf MB, Abedin T, Hugh J, King K, Bigras G, Steed T, Lupichuk S. Batra A, et al. Among authors: lupichuk s. Cancer Treat Res Commun. 2021;28:100401. doi: 10.1016/j.ctarc.2021.100401. Epub 2021 May 26. Cancer Treat Res Commun. 2021. PMID: 34091374 Free article.
Optimal use of taxanes in metastatic breast cancer.
King KM, Lupichuk S, Baig L, Webster M, Basi S, Whyte D, Rix S. King KM, et al. Among authors: lupichuk s. Curr Oncol. 2009 May;16(3):8-20. doi: 10.3747/co.v16i3.377. Curr Oncol. 2009. PMID: 19526080 Free PMC article.
Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer.
Rayson D, Lupichuk S, Potvin K, Dent S, Shenkier T, Dhesy-Thind S, Ellard SL, Prady C, Salim M, Farmer P, Allo G, Tsao MS, Allan A, Ludkovski O, Bonomi M, Tu D, Hagerman L, Goodwin R, Eisenhauer E, Bradbury P. Rayson D, et al. Among authors: lupichuk s. Breast Cancer Res Treat. 2016 May;157(1):109-16. doi: 10.1007/s10549-016-3812-1. Epub 2016 Apr 26. Breast Cancer Res Treat. 2016. PMID: 27116183 Clinical Trial.
Adjuvant breast radiotherapy, endocrine therapy, or both after breast conserving surgery in older women with low-risk breast cancer: Results from a population-based study.
Joseph K, Zebak S, Alba V, Mah K, Au C, Vos L, Ghosh S, Abraham A, Chafe S, Wiebe E, Liu HW, Chambers C, Gabos Z, Tankel K, Lupichuk S, King K. Joseph K, et al. Among authors: lupichuk s. Radiother Oncol. 2021 Jan;154:93-100. doi: 10.1016/j.radonc.2020.09.017. Epub 2020 Sep 14. Radiother Oncol. 2021. PMID: 32941956
37 results